Professional Documents
Culture Documents
1
Department of Psychiatry,
SUMMARY University of Cincinnati College
Review criteria
We reviewed the epidemiology, pathophysiology and of Medicine, Cincinnati, OH,
Aims: Fibromyalgia (FM), a chronic disorder defined by widespread pain, often
USA
accompanied by fatigue and sleep disturbance, affects up to one in 20 patients in management of fibromyalgia (FM) by searching 2
Department of Family
English-language publications in PubMed, and
primary care. Although most patients with FM are managed in primary care, diag- Medicine, Indiana University
references from relevant articles, published before School of Medicine,
nosis and treatment continue to present a challenge, and patients are often
May 2015. The main search terms were fibromyalgia, Indianapolis, IN, USA
referred to specialists. Furthermore, the lack of a clear patient pathway often epidemiology, pathophysiology, diagnosis, primary 3
Department of Medicine,
results in patients being passed from specialist to specialist, exhaustive investiga- care, secondary care, treatment and patient-centred Cardiff University School of
tions, prescription of multiple drugs to treat different symptoms, delays in diagno- medical home. We selected articles on the basis of Medicine, Cardiff, UK
sis, increased disability and increased healthcare resource utilisation. We will quality, relevance to the illness and importance in
illustrating current management pathways and the Correspondence to:
discuss the current and evolving understanding of FM, and recommend improve-
Lesley M. Arnold, Department
ments in the management and treatment of FM, highlighting the role of the pri- potential for future improvements.
of Psychiatry, University of
mary care physician, and the place of the medical home in FM management. Cincinnati College of Medicine,
Message for the clinic 260 Stetson Street Suite 3200,
Methods: We reviewed the epidemiology, pathophysiology and management of
The management pathway for FM currently is often Cincinnati, OH 45219, USA
FM by searching PubMed and references from relevant articles, and selected arti- lengthy and complex, involving repeated clinic visits, Tel.: + 1 513 558 4622
cles on the basis of quality, relevance to the illness and importance in illustrating unnecessary referrals and costly tests. The medical Fax: + 1 513 558 4280
current management pathways and the potential for future improvements. home, a patient-centred management framework Email: lesley.arnold@uc.edu
Results: The implementation of a framework for chronic pain management in pri- which has been successfully implemented in other
mary care would limit unnecessary, time-consuming, and costly tests, reduce diag- chronic diseases, might provide the key to reducing
nostic delay and improve patient outcomes. Discussion: The patient-centred diagnosis time and improving patient outcomes.
Disclosures
Effective approaches to helping practices adopt the
medical home (PCMH), a management framework that has been successfully Dr Arnold reports grants and
medical home and tailor it to the needs of patients personal fees from Daiichi
implemented in other chronic diseases, might improve the care of patients with
with FM will be important. Sankyo, Pfizer, Forest, and
FM in primary care, by bringing together a team of professionals with a range of
Theravance; personal fees from
skills and training. Conclusion: Although there remain several barriers to over- Dainippon Sumitomo Pharma,
come, implementation of a PCMH would allow patients with FM, like those with Purdue, Toray, Shire, Innovative
other chronic conditions, to be successfully managed in the primary care setting. Med Concepts, Ironwood, and
Zynerba; and grants from
Takeda, Tonix, Cerephex
Corporation, and Eli Lilly and
Fibromyalgia continues to present a challenge for
Introduction Company outside the submitted
healthcare professionals (HCPs) (7). The extensive work. Dr Gebke reports
Fibromyalgia (FM) is a common, potentially dis- array of symptoms associated with, and gradual evo- personal fees from Pfizer
outside the submitted work. Dr
abling, chronic disorder that is defined by wide- lution of, FM make it difficult to diagnose in pri-
Choy reports personal fees from
spread pain, often accompanied by fatigue and sleep mary care settings (7,8), and the condition is often Daiichi Sankyo, Inc., during the
disturbance, and associated with other symptoms under-diagnosed (5). One study has shown that diag- conduct of the study and
personal fees from Pfizer,
including depression, cognitive dysfunction (e.g. for- nosis of FM might take more than 2 years, with
Tonix, and Eli Lilly, outside the
getfulness, decreased concentration), irritable bowel patients seeing an average of 3.7 different physicians submitted work.
syndrome (IBS) and headache (1,2). In the general during this time (8). Although the American College
population, the estimated global prevalence of FM is of Rheumatology (ACR) has published diagnostic
2.7% (4.2% female, 1.4% male) (2). In primary care, criteria for FM (9,10), these are not widely used in
studies suggest that up to one in 20 patients has FM clinical practice, and there remains a knowledge gap
symptoms (3), and this number is increasing as among some HCPs, particularly in the primary care
growing recognition of FM by patients leads to an setting (7,8,11,12). In addition to diagnostic com-
upsurge in presentation for diagnosis and treatment plexity, therapeutic management might be problem-
(4,5). The cause of FM is not known, but research atic (13), and there is a lack of prescribing
studies suggest genetic predisposition and possible consistency between physicians (14,15). Many
triggering events (6). patients might not receive treatment, and for those
ª 2016 The Authors International Journal of Clinical Practice Published by John Wiley & Sons Ltd
Int J Clin Pract, February 2016, 70, 2, 99–112. doi: 10.1111/ijcp.12757 99
This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and
distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
100 Fibromyalgia management for primary care providers
Table 1 Differences between the ACR 1990 (1) and the revised ACR 2010 (9) criteria for FM
1990 2010
ACR, American College of Rheumatology; FM, fibromyalgia; SS, symptom severity; WPI, Widespread Pain Index.
ª 2016 The Authors International Journal of Clinical Practice Published by John Wiley & Sons Ltd
Int J Clin Pract, February 2016, 70, 2, 99–112
Fibromyalgia management for primary care providers 101
ened sensitivity to stimuli that are not normally treatment expectations (e.g. ethnic variance in the
painful), and hyperalgesia (an increased response to level of pain perception) (30). Furthermore, prescrib-
painful stimuli) (5,22,23). Patients with FM therefore ing practices might differ according to whether a
experience pain for what patients without FM per- patient is seen by a primary care physician or a spe-
ceive as touch, and exhibit an increased sensitivity cialist, on the HCP’s familiarity with treatment
and/or a decreased threshold to a variety of inputs guidelines, and on the availability of local resources
including heat, cold, auditory and electrical stimuli for disease management.
(21,22). This theory of central sensitisation or central Finally, the lack of a clear patient pathway and
augmentation helps to explain both the heteroge- healthcare system for diagnosis and management of
neous clinical aspects of FM and several of the asso- FM often results in patients being passed from physi-
ciated symptoms, because many of the same cian to physician, receiving multiple drugs to treat
neurotransmitters that control pain and sensory sen- different symptoms and suffering increased disability
sitivity also control sleep, mood, memory and alert- (12,30,34). Many primary care physicians still prefer
ness (4,21). to refer the patient to a specialist (7), particularly
Fibromyalgia can develop at any age, including when patients have multiple comorbidities that are
childhood, although the peak age is usually mid- likely to require a considerable amount of time to
life (6,24), and while the exact causes of FM are investigate and manage. However, the majority of
unclear, they are thought to involve both environ- FM cases could be diagnosed and treated in primary
mental (mental or physical trauma, prior medical care, and a patient-centric multidisciplinary approach
illness) and genetic factors (first-degree relatives of to FM in primary care would result in more rapid
patients with FM have an eightfold increased likeli- diagnosis, more effective management, improved
hood of developing FM) (24–26). FM is a poten- outcomes for patients and better use of health
tially disabling condition with a high burden of resources (4,35).
illness (14,27). FM is also associated with a num-
ber of common comorbidities including cardiac Unmet needs
disorders, psychiatric disorders, sleep disturbances, Despite improvements in the understanding of the
IBS, chronic fatigue syndrome, interstitial cystitis, condition, FM remains under-diagnosed and under-
headache/migraine, hypertension, obesity and disor- treated. A large proportion of physicians, particularly
ders of lipid metabolism, which might add to the in primary care, report unclear diagnostic criteria, a
overall disability burden and amplify treatment lack of confidence in using the ACR criteria for diag-
costs (5,28,29). nosis, insufficient training/skill in diagnosing FM and
a lack of knowledge of treatment options (7,11,13).
Barriers to managing FM in primary care Furthermore, both patients and physicians express
Although our understanding of FM has increased dissatisfaction with the delays in reaching a diagnosis
considerably in recent years, the barriers to diagno- and obtaining effective treatment (12). Several sur-
sis and optimal treatment are many and varied. veys of patients with FM have reported dissatisfac-
Globally, there are inconsistencies in the recognition tion with FM medication and overall treatment
of symptoms, and in the validity of FM as a diag- (8,16,36). A survey of 800 patients reported that 35%
nosis (13). Even where guidelines are available, believed that their chronic, widespread pain was not
physicians in different regions may have varying well managed by their current treatment, and 22%
levels of awareness of these guidelines. This, in turn, were not satisfied with the impact of their treatment
results in wide variations in the time to diagnosis on fatigue (8).
of FM between geographical regions (ranging from
2.6 to 5 years in the USA, Latin America and Diagnosis of FM
Europe) (5,30). Fibromyalgia is a disease with unique clinical charac-
In addition to diagnostic barriers, there are major teristics, making it suitable for diagnosis in the pri-
inconsistencies between treatment practices. There is mary care setting. Prompt diagnosis of the disorder
still some debate over the optimal choice and is an essential component of successful FM manage-
sequence of treatments for FM (31), and the ment (18). Studies have shown that a diagnosis of
approval status, availability and reimbursement of FM is associated with improved satisfaction with
therapeutic agents varies between countries (32). health, and a reduction in the utilisation of medical
Treatment guidelines currently make varying recom- resources and the associated costs (in particular, a
mendations, possibly because of different criteria reduction in referrals and investigations), relative to
used to grade recommendations (33), and there patients with FM symptoms who remain undiag-
might also be cultural differences regarding patient nosed (37,38).
ª 2016 The Authors International Journal of Clinical Practice Published by John Wiley & Sons Ltd
Int J Clin Pract, February 2016, 70, 2, 99–112
102 Fibromyalgia management for primary care providers
ª 2016 The Authors International Journal of Clinical Practice Published by John Wiley & Sons Ltd
Int J Clin Pract, February 2016, 70, 2, 99–112
Fibromyalgia management for primary care providers 103
activity of facilitatory neurotransmitters (which ‘turn turbances) alongside pain, the presence of
up the pain volume’) (6). In contrast, there are cur- comorbidities such as anxiety or rheumatic disease,
rently no medications approved for the treatment of and the tolerability profile of the therapeutic options
FM in Europe, even though pregabalin, duloxetine (6). Patients with FM often require multiple medica-
and milnacipran have all been approved in Europe tions to treat their symptoms and comorbidities, and
for other indications (32). Table 2 summarises the guidance on possible medication combinations has
FDA-approved pharmacological treatment options been previously published (54). It is important to
for FM. Titration to the therapeutic dose is recom- select combination therapies that are not associated
mended to improve patient response. In some with adverse drug–drug interactions.
patients, starting at a lower dose and titrating more
slowly may be necessary to lessen the risk of intolera- Non-pharmacological treatments
bility and discontinuation of treatment. Non-pharmacological treatments should be an inte-
Other medications such as amitriptyline, cycloben- gral component of a prescribed treatment plan for
zaprine, gabapentin and fluoxetine have demon- patients with FM (31). Patient education, exercise,
strated efficacy in randomised, controlled trials of some forms of cognitive behavioural therapy (CBT),
FM and are commonly used to treat FM, although and sleep hygiene are the most-studied non-pharma-
they are not approved for this indication by the FDA cological treatments and have demonstrated efficacy
(52–54). The selection of pharmacological agent(s) in patients with FM (4,6).
for the management of FM should be tailored Educational materials for patients are widely avail-
according to a number of factors, including the pres- able on the Internet from many Web sites, including
ence of additional symptoms (e.g. fatigue, sleep dis- those run by the ACR (http://www.rheumatol-
FDA Mechanism
Drug approval of action Efficacy studies Primary end-points Dosing Adverse events*
Duloxetine 16 June SNRI • 3 months, Pain reduction, 60 mg/day; start Nausea, dry mouth,
2008 randomised, improvements in PGIC 30 mg/day for somnolence,
double-blind, and FIQ 1 week then constipation,
placebo-controlled increase to decreased appetite,
• 6 months, 60 mg/day hyperhidrosis
randomised,
double-blind,
placebo-controlled
Milnacipran 14 January SNRI • 3 months, Composite end-point 100 mg/day; start Nausea,
2009 randomised, that concurrently 12.5 mg/day, constipation, hot
double-blind, evaluated increasing flush, hyperhidrosis,
placebo-controlled improvement in pain incrementally to vomiting,
• 6 months, (VAS), physical 50 mg bid in palpitations,
randomised, function (SF-36 PCS) 1 week; maximum increased heart
double-blind, and patient global dose 100 mg bid rate, dry mouth,
placebo-controlled assessment (PGIC) hypertension
bid, twice daily; FDA, US Food and Drug Administration; FIQ, Fibromyalgia Impact Questionnaire; FM, fibromyalgia; PGIC, patient global
impression of change; SF-36 PCS, Short-Form 36 Physical Component Summary; SNRI, serotonin-norepinephrine re-uptake inhibitor; VAS,
visual analogue scale.
*The most commonly reported adverse events are shown. For full details, please refer to the prescribing information for each drug.
ª 2016 The Authors International Journal of Clinical Practice Published by John Wiley & Sons Ltd
Int J Clin Pract, February 2016, 70, 2, 99–112
104 Fibromyalgia management for primary care providers
ª 2016 The Authors International Journal of Clinical Practice Published by John Wiley & Sons Ltd
Int J Clin Pract, February 2016, 70, 2, 99–112
Fibromyalgia management for primary care providers 105
Patient Provide core information Can improve symptoms and • Can be carried out as • Might need to be
education about diagnosis, treatment functionality; might reduce part of normal repeated during each
and prognosis; manage disability levels consultations consultation or require
expectations separate educational
sessions
• Might be
time-consuming
• Might require
additional support staff to
help provide education
Exercise Start low, go slow: build up Can improve physical • Easily incorporated into • Might cause worsening
to moderate activity over function, quality of life daily routine of symptoms if exercise
time and reduce symptoms of • Even small increases in programme is begun too
pain and depression activity have been shown rapidly
to be of value • Access to exercise
facilities might be limited
• Might require
consultation with
other HCPs (e.g. physical
therapists)
CBT Face-to-face counselling, Provides knowledge about • Effective in one-on-one • Most effective when
online self-help courses, FM and coping strategies. settings, small groups and combined with other
books, CDs, FM Web sites Can provide sustained via the Internet treatments
improvements in FM • Internet-based • Access to mental health
symptoms, and reduce programmes provide providers might be limited
impact on daily life convenience for patients and might be costly
Sleep Optimise sleep environment Can improve pain scores • Easily incorporated into • Patient might be
hygiene and prioritise relaxing sleep and mental well-being daily routine resistant to changes in
routine routine (e.g. avoiding
coffee at night, not
watching television in bed)
CAM Various: examples include tai Can increase patient • Limited evidence for • Most CAM therapies
therapies chi, yoga, massage, diet, self-sufficiency and efficacy have not been rigorously
balneotherapy and improve pain/functioning studied
acupuncture • Limited access to some
of these treatments in
some communities
• Might be costly
CAM, complementary and alternative medicine; CBT, cognitive behavioural therapy; FM, fibromyalgia; HCP, healthcare professional.
ment plan based on prioritising the areas that affect Integrated multimodal treatment
them most (4). While some patients might simply A comprehensive treatment plan should include
want a reduction in pain, others might prefer to focus non-pharmacological treatments, pharmacological
on obtaining restorative sleep, or reducing fatigue therapies and active patient coping strategies. As FM
levels to improve work or family relationships (17). is associated with a constellation of symptoms, no
These goals should be established early after diagno- single treatment can be expected to target every one
sis, to provide structure and guidance for future con- of them. The treatment approach must be flexible to
sultations and treatment decisions, but it is important incorporate changes as the condition progresses, and
that they be realistic, specific and easily tracked to it is likely to require the collaboration of a number
provide a measure of treatment benefit (4). of HCPs, particularly for the treatment of some
ª 2016 The Authors International Journal of Clinical Practice Published by John Wiley & Sons Ltd
Int J Clin Pract, February 2016, 70, 2, 99–112
106 Fibromyalgia management for primary care providers
comorbidities (4). Patients can be encouraged to monitoring scales, to rapidly gain a clear picture of
identify and maintain active coping strategies, in an symptom control and therapeutic outcome (35).
attempt to reduce disability (34). Comorbidities,
such as severe depression or marked psychosocial The medical home for management of FM
stressors, might necessitate referral to a mental health It is possible to transform primary care into a system
specialist, while medical comorbidities might require in which medical practices can be improved to pro-
additional treatment from a range of specialists such vide team-based care and data-driven integrated
as rheumatologists, gastroenterologists and sleep spe- delivery, using the concept of the patient-centred
cialists. The primary care physician plays an impor- medical home (PCMH). In the PCMH, decision
tant role in coordinating specialists and ancillary making is guided by evidence-based medicine and
HCPs to provide continuity of care for the patient. decision-support tools. Patients are active partners in
their treatment and information technology is uti-
Tracking progress lised to support education, communication, data col-
Surveys of HCPs have reported that many primary lection and performance measurement (57,58). The
care physicians report a lack of knowledge of treat- principles of the medical home were developed by
ment options and monitoring tools (11). This is a key organisations, including the American College of
key limitation, because it is only by tracking symp- Physicians and the American Academy of Family
tom presence and severity that the impact of treat- Physicians. The aim of a PCMH was to provide
ment can be evaluated. There are several scales and comprehensive primary care for all ages and
questionnaires available that have been developed to throughout all stages of life, by coordinating and
evaluate the different symptoms of FM, and these integrating care (chronic, acute, preventative and
might be useful to provide an initial health status, end-of-life) across all elements of the healthcare sys-
and a marker from which progress can be tracked tem, to improve efficiency and effectiveness (Fig-
(4,35). However, such tools need to be reliable, vali- ure 1) (57,58).
dated in patients with FM, rapid to administer and While the PCMH may not be feasible in all prac-
easy to interpret, to be globally accepted and used tices (owing to an absence or scarcity of resources)
routinely in the clinic. or in all countries (due to the widely varying health-
care systems between nations), it can provide a
Using electronic records vision for the future management of FM and other
The use of computers and technology is now ubiqui- chronic conditions by demonstrating how integration
tous throughout society, and health care is no excep- and coordination of doctors, hospitals, pharmacies
tion. In recent years, HCPs have moved towards and community resources can improve patient expe-
keeping electronic records, providing an opportunity rience and outcomes while potentially reducing waste
to integrate FM management, improve outcomes and and inefficiency (59,60). The changing landscape of
reduce costs and unnecessary testing (35). Electronic health management across the US and elsewhere
records can improve access to patient information (60–64) provides an opportunity for many HCPs
across multiple specialties that might be involved in and practices to implement a chronic care framework
care decisions, provide information to guide pre- for FM management, similar to that already in use
scribing decisions according to current recommenda- for diabetes (4). Results to date indicate that the
tions, reduce medication errors and possibly aid in PCMH is a viable mechanism to qualitatively
identifying undiagnosed patients (35). In a recent improve diabetes management, while potentially
retrospective analysis, it was shown that a potential reducing the costs of long-term care (65–68). The
diagnosis of FM was associated with more frequent PCMH concept has also been successfully imple-
emergency room visits, outpatient visits, and hospi- mented in the field of mental health, resulting in
talisations and higher medication use. The authors reduced rates of hospitalisations, fewer specialty care
concluded that all of these variables could be identi- visits and increased primary care consultations for
fied from electronic medical records, suggesting that patients with conditions such as post-traumatic stress
routine data collection and input could have a direct disorder (69,70). However, of all the patients treated
application to FM diagnosis and care management in primary care, those with chronic pain are most in
(56). need of practice reform (71). The first steps towards
For HCPs, identification of patients undergoing improving FM care have already been taken, with
multiple exploratory tests might aid in focusing recent publications from the USA and the UK laying
resources, to break the cycle of long-term medical the groundwork for a focused and supported man-
spending. Online or application-based tools could agement pathway for patients with FM and chronic
also expedite administration and interpretation of pain (4,34,48). It is hoped that by addressing the
ª 2016 The Authors International Journal of Clinical Practice Published by John Wiley & Sons Ltd
Int J Clin Pract, February 2016, 70, 2, 99–112
Fibromyalgia management for primary care providers 107
Comprehensive
care
Robust health IT systems; Focus on strong
ability to track milestones relationships with
and outcomes resulting in physicians and care team;
optimal use of medication, patients are less likely to
Quality and Patient
and fewer unneccessary seek care from the
safety centred
referrals emergency room
The PCMH
Accessible Coordinated
Consumer-friendly, multi- Care is documented and
services care
platform approach to communicated effectively
access; patients are more across providers; fewer
likely to seek care, in the dupicate tests and better
right place, and at the chronic disease
right time management
Figure 1 The PCMH: framework and principles. IT, information technology; PCMH, patient-centred medical home
current challenges and suggesting potential areas for conditions, registered nurses or health coaches are
restructuring, proposals for PCMH implementation likely to be a key among these team members,
and FM management in primary care can be imple- enabling patients to understand their condition, and
mented rapidly and smoothly into current practices. instructing them in the mechanisms and benefits of
self-management (76–78). Since patients with FM
Implementing a medical home for FM commonly have psychiatric comorbidities, beha-
vioural health workers might also be a necessary
Personnel adjunct to the team, alongside care coordinators, a
One obvious factor affecting the adoption of any largely clerical role, but pivotal to ensuring referrals
new primary care framework is practice size. Small are made and followed up (76–78).
practices, with just one or two physicians, are The aim of the PCMH is to engage multiple HCPs
unlikely to have either the personnel or the systems in providing hands-on management to assist patients
to be able to fully implement the PCMH concept in navigating the care system. This requires a team-
(72). However, the current trend in the USA is based approach, to spread the load, maximise effi-
towards larger practice sizes, since they might enjoy ciency and make the best use of each team member’s
economies of scale, whereby several physicians can professional skills (79). One of the key ingredients of
share support staff (72,73). a successful PCMH is effective leadership within the
In the PCMH model, a typical primary care office practice, both to facilitate the transition and to serve
is likely to require two to four support staff for each as the patient’s primary care provider (62). Depend-
physician (74,75). In an office with four to six full- ing on state law, this leadership might come from a
time employees, this is likely to mean two full-time physician or from a nurse practitioner (78–80). In
physicians and several part-time support staff in vari- either case, the individual must be able to meld
ous ratios. Support staff commonly includes regis- diverse personalities with widely differing levels of
tered nurses, physician assistants, nurse practitioners training into a cohesive team, all members of which
and medical assistants (see Appendix 1), as well as a are functioning at the highest level and contributing
pharmacist, who might be shared between several to the health of their patients (81,82). Conversely,
practices (74,75). For FM, and other chronic pain one potential obstacle to overcome might be a reluc-
ª 2016 The Authors International Journal of Clinical Practice Published by John Wiley & Sons Ltd
Int J Clin Pract, February 2016, 70, 2, 99–112
108 Fibromyalgia management for primary care providers
tance to delegate or re-allocate tasks. Staff familiar However, physicians should not be discouraged
with the PCMH or external facilitators might be from implementing at least some aspects of the
needed during the transition period to ensure that PCMH, and should seek advice from experienced
authority and responsibility are shared by the entire healthcare advisors who will be able to assess the abil-
team (76,81,82). ity of each practice to meet the PCMH requirements
Ultimately, transitioning a primary care practice to or develop other viable options that may be better
a PCMH can have many benefits for the HCPs suited to the needs and capabilities of any given prac-
involved. Primary care physicians have reported tice. Furthermore, financial support, training and
increased job satisfaction, because they have an technical aid may be available to assist in the transi-
improved HCP–patient relationship, and are better tion process towards PCMH recognition (59,64,83).
able to focus on the more complex aspects of care
(76). Medical assistants and nursing staff report Best practice
improved job satisfaction from the increased respon- For a patient such as Susan, getting a diagnosis of
sibility and feeling more involved in patient care FM often takes several years, many examinations and
(76). Furthermore, PCMH reform can help to procedures, and multiple visits to various doctors.
improve primary care attitudes towards patients with However, implementation of a medical home is an
chronic pain, by providing incentives and increasing opportunity to reduce the timescale between presen-
opportunities for specialised education and training tation and diagnosis, and revise the scenario to limit
(71). unnecessary tests and referrals. FM is a clinical diag-
nosis that can be appropriately made by primary care
Challenges physicians based on the clinical characteristics of the
While the PCMH is an appealing proposition in disorder. Faster symptom recognition and diagnosis
terms of benefit to patients and HCPs, there are also might be possible, to enable earlier treatment initia-
several challenges associated with the concept, which tion. The PCMH has been shown to improve out-
need to be carefully considered prior to initiating comes in diabetes and mental health; thus, it should
practice reform. Significant time and expense may be be viable to adapt the model for FM and chronic
needed to meet the required criteria and benchmarks pain.
(58–60,83), which may tax the resources of small
practices and solo practitioners. It may be necessary Case study: Susan King
to hire additional staff to meet the management and
Current symptoms: In addition to widespread pain, Susan reports
administrative demands of PCMH operations,
regular sleepless nights, resulting in feeling unrefreshed
upgrade and maintain IT infrastructure, and establish and tired for most of the day. She feels that she is
the type of electronic records network necessary to not ‘clear-headed’ and is unable to concentrate on regular
fulfil PCMH technology and access requirements tasks at times. Her fatigue means that she is so exhausted
(58,62). Geographical location may also be an issue, after work that she is unable to interact with her husband and
because a small rural practice without adequate local daughter, or take part in normal social activities. Susan is also
specialists, non-physician HCPs or supportive com- conscious that since she is sedentary at her job, she should
munity resources may be limited in its ability to make time for physical exercise. However, although she
meet collaborative care standards (83). previously participated in regular aerobic exercise, she has not
exercised in the past 9 months due to always feeling tired.
With further enquiry, Susan remembers that during her
childhood, her mother also had similar complaints
Case study: Susan King
ª 2016 The Authors International Journal of Clinical Practice Published by John Wiley & Sons Ltd
Int J Clin Pract, February 2016, 70, 2, 99–112
Fibromyalgia management for primary care providers 109
ª 2016 The Authors International Journal of Clinical Practice Published by John Wiley & Sons Ltd
Int J Clin Pract, February 2016, 70, 2, 99–112
110 Fibromyalgia management for primary care providers
medical home and tailor it to the needs of the patient financial remuneration for the writing of this manu-
with chronic pain will be important. Although there script. The authors thank Sally-Anne Mitchell, PhD
remain several barriers to overcome, implementation of (ApotheCom, Yardley, PA) for editorial assistance
a PCMH for chronic pain would allow FM to be with this manuscript. This assistance was funded by
successfully managed in the primary care setting. Daiichi Sankyo, Inc.
tional study in the United States. Curr Med Res 31 Ablin J, Fitzcharles MA, Buskila D et al. Treatment
References Opin 2011; 27: 673–83. of fibromyalgia syndrome: recommendations of
16 Robinson RL, Kroenke K, Williams DA et al. Lon- recent evidence-based interdisciplinary guidelines
1 Wolfe F, Smythe HA, Yunus MB et al. The American
gitudinal observation of treatment patterns and with special emphasis on complementary and alter-
College of Rheumatology 1990 Criteria for the Classi-
outcomes for patients with fibromyalgia: 12-month native therapies. Evid Based Complement Altern
fication of Fibromyalgia. Report of the Multicenter
findings from the reflections study. Pain Med 2013; Med 2013; 2013: 485272.
Criteria Committee. Arthritis Rheum 1990; 33: 160–72.
14: 1400–15. 32 Briley M. Drugs to treat fibromyalgia – the transat-
2 Queiroz LP. Worldwide epidemiology of fibromyal-
17 O’Brien EM, Staud RM, Hassinger AD et al. lantic difference. Curr Opin Investig Drugs 2010; 11:
gia. Curr Pain Headache Rep 2013; 17: 356.
Patient-centered perspective on treatment outcomes 16–8.
3 Glennon P. Fibromyalgia syndrome: management
in chronic pain. Pain Med 2010; 11: 6–15. 33 Hauser W, Thieme K, Turk DC. Guidelines on the
in primary care. Rep Rheum Dis 2010; series 6: 1–6.
18 Goldenberg DL, Burckhardt C, Crofford L. Man- management of fibromyalgia syndrome – a system-
4 Arnold LM, Clauw DJ, Dunegan LJ, Turk DC. A
agement of fibromyalgia syndrome. JAMA 2004; atic review. Eur J Pain 2010; 14: 5–10.
framework for fibromyalgia management for primary
292: 2388–95. 34 Price C, Lee J, Taylor AM, Baranowski AP. Initial
care providers. Mayo Clin Proc 2012; 87: 488–96.
19 Fillingim RB, King CD, Ribeiro-Dasilva MC, assessment and management of pain: a pathway for
5 Arnold LM, Clauw DJ, McCarberg BH. Improving
Rahim-Williams B, Riley JL III. Sex, gender, and care developed by the British Pain Society. Br J
the recognition and diagnosis of fibromyalgia.
pain: a review of recent clinical and experimental Anaesth 2014; 112: 816–23.
Mayo Clin Proc 2011; 86: 457–64.
findings. J Pain 2009; 10: 447–85. 35 Wells AF, Arnold LM, Curtis CE et al. Integrating
6 Clauw DJ. Fibromyalgia: a clinical review. JAMA
20 Vincent A, Lahr BD, Wolfe F et al. Prevalence of health information technology and electronic health
2014; 311: 1547–55.
fibromyalgia: a population-based study in Olmsted records into the management of fibromyalgia. Post-
7 Hadker N, Garg S, Chandran AB et al. Primary care
County, Minnesota, utilizing the Rochester Epi- grad Med 2013; 125: 70–7.
physicians’ perceptions of the challenges and barriers
demiology Project. Arthritis Care Res 2013; 65: 36 Lauche R, Hauser W, Jung E et al. Patient-related
in the timely diagnosis, treatment and management
786–92. predictors of treatment satisfaction of patients
of fibromyalgia. Pain Res Manag 2011; 16: 440–4.
21 Clauw DJ, Arnold LM, McCarberg BH. The science with fibromyalgia syndrome: results of a cross-
8 Choy E, Perrot S, Leon T et al. A patient survey of
of fibromyalgia. Mayo Clin Proc 2011; 86: 907–11. sectional survey. Clin Exp Rheumatol 2013; 31:
the impact of fibromyalgia and the journey to diag-
22 Phillips K, Clauw DJ. Central pain mechanisms in S34–40.
nosis. BMC Health Serv Res 2010; 10: 102.
chronic pain states–maybe it is all in their head. 37 Annemans L, Wessely S, Spaepen E et al. Health
9 Wolfe F, Clauw DJ, Fitzcharles MA et al. The Ameri-
Best Pract Res Clin Rheumatol 2011; 25: 141–54. economic consequences related to the diagnosis of
can College of Rheumatology preliminary diagnostic
23 Staud R. Abnormal endogenous pain modulation is fibromyalgia syndrome. Arthritis Rheum 2008; 58:
criteria for fibromyalgia and measurement of symp-
a shared characteristic of many chronic pain condi- 895–902.
tom severity. Arthritis Care Res 2010; 62: 600–10.
tions. Expert Rev Neurother 2012; 12: 577–85. 38 Hughes G, Martinez C, Myon E, Taieb C, Wes-
10 Wolfe F, Clauw DJ, Fitzcharles MA et al.
24 Crofford LJ. Fibromyalgia. Atlanta, GA: American sely S. The impact of a diagnosis of fibromyalgia
Fibromyalgia criteria and severity scales for clinical
College of Rheumatology, 2013. on health care resource use by primary care
and epidemiological studies: a modification of the
25 Mease P. Fibromyalgia syndrome: review of clinical patients in the UK: an observational study based
ACR Preliminary Diagnostic Criteria for
presentation, pathogenesis, outcome measures, and on clinical practice. Arthritis Rheum 2006; 54:
Fibromyalgia. J Rheumatol 2011; 38: 1113–22.
treatment. J Rheumatol Suppl 2005; 75: 6–21. 177–83.
11 Gulec H, Sayar K, Yazici GM. The relationship
26 Arnold LM, Hudson JI, Hess EV et al. Family study 39 Staud R. Chronic widespread pain and fibromyal-
between psychological factors and health care-seek-
of fibromyalgia. Arthritis Rheum 2004; 50: 944–52. gia: two sides of the same coin? Curr Rheumatol
ing behavior in fibromyalgia patients. Turk Psikiya-
27 Perrot S, Winkelmann A, Dukes E et al. Character- Rep 2009; 11: 433–6.
tri Dergisi 2007; 18: 22–30.
istics of patients with fibromyalgia in France and 40 Haliloglu S, Carlioglu A, Akdeniz D, Karaaslan Y,
12 Briones-Vozmediano E, Vives-Cases C, Ronda-
Germany. Int J Clin Pract 2010; 64: 1100–8. Kosar A. Fibromyalgia in patients with other
Perez E, Gil-Gonzalez D. Patients’ and profession-
28 Haviland MG, Banta JE, Przekop P. Fibromyalgia: rheumatic diseases: prevalence and relationship
als’ views on managing fibromyalgia. Pain Res
prevalence, course, and co-morbidities in hospital- with disease activity. Rheumatol Int 2014; 34:
Manag 2013; 18: 19–24.
ized patients in the United States, 1999-2007. Clin 1275–80.
13 Hayes SM, Myhal GC, Thornton JF et al.
Exp Rheumatol 2011; 29: S79–87. 41 Davis JA, Robinson RL, Le TK, Xie J. Incidence
Fibromyalgia and the therapeutic relationship:
29 White LA, Birnbaum HG, Kaltenboeck A et al. and impact of pain conditions and comorbid ill-
where uncertainty meets attitude. Pain Res Manag
Employees with fibromyalgia: medical comorbidity, nesses. J Pain Res 2011; 4: 331–45.
2010; 15: 385–91.
healthcare costs, and work loss. J Occup Environ 42 Ahmad J, Tagoe CE. Fibromyalgia and chronic
14 Robinson RL, Kroenke K, Mease P et al. Burden of
Med 2008; 50: 13–24. widespread pain in autoimmune thyroid disease.
illness and treatment patterns for patients with
30 Clark P, Paiva ES, Ginovker A, Salomon PA. A Clin Rheumatol 2014; 33: 885–91.
fibromyalgia. Pain Med 2012; 13: 1366–76.
patient and physician survey of fibromyalgia across 43 Ablin JN, Buskila D. “Real-life” treatment of
15 McNett M, Goldenberg D, Schaefer C et al. Treat-
Latin America and Europe. BMC Musculoskelet Dis- chronic pain: targets and goals. Best Pract Res Clin
ment patterns among physician specialties in the
ord 2013; 14: 188. Rheumatol 2015; 29: 111–9.
management of fibromyalgia: results of a cross-sec-
ª 2016 The Authors International Journal of Clinical Practice Published by John Wiley & Sons Ltd
Int J Clin Pract, February 2016, 70, 2, 99–112
Fibromyalgia management for primary care providers 111
44 Podolecki T, Podolecki A, Hrycek A. Fibromyalgia: 60 Faber M, Voerman G, Erler A et al. Survey of 5 74 Hsu C, Coleman K, Ross TR et al. Spreading a
pathogenetic, diagnostic and therapeutic concerns. European countries suggests that more elements of patient-centered medical home redesign: a case
Pol Arch Med Wewn 2009; 119: 157–61. patient-centered medical homes could improve pri- study. J Ambul Care Manag 2012; 35: 99–108.
45 Bennett RM, Jones J, Turk DC, Russell IJ, Matallana mary care. Health Aff (Millwood) 2013; 32: 797–806. 75 Patel MS, Arron MJ, Sinsky TA et al. Estimating
L. An internet survey of 2,596 people with fibromyal- 61 Nielson M, Gibson A, Buelt L, Grundy P, Grum- the staffing infrastructure for a patient-centered
gia. BMC Musculoskelet Disord 2007; 8: 27. bach K. The Patient-Centered Medical Home’s medical home. Am J Manag Care 2013; 19: 509–16.
46 Mease PJ, Dundon K, Sarzi-Puttini P. Pharma- Impact on Cost and Quality. Annual Review of Evi- 76 O’Malley AS, Gourevitch R, Draper K, Bond A,
cotherapy of fibromyalgia. Best Pract Res Clin dence 2013-2014. Washington, DC: Patient-Cen- Tirodkar MA. Overcoming challenges to teamwork
Rheumatol 2011; 25: 285–97. tered Primary Care Collaborative, 2015. in patient-centered medical homes: a qualitative
47 Sanchez RJ, Uribe C, Li H et al. Longitudinal eval- 62 Tirodkar MA, Morton S, Whiting T et al. There’s study. J Gen Intern Med 2015; 30: 183–92.
uation of health care utilization and costs during more than one way to build a medical home. Am J 77 Moran KJ, Burson R. Understanding the patient-
the first three years after a new diagnosis of Manag Care 2014; 20: e582–9. centered medical home. Home Healthc Nurse 2014;
fibromyalgia. Curr Med Res Opin 2011; 27: 663–71. 63 Jackson GL, Powers BJ, Chatterjee R et al. Improving 32: 476–81.
48 Lee J, Ellis B, Price C, Baranowski AP. Chronic patient care. The patient centered medical home. A sys- 78 Henderson S, Princell CO, Martin SD. The patient-
widespread pain, including fibromyalgia: a pathway tematic review. Ann Intern Med 2013; 158: 169–78. centered medical home: this primary care model
for care developed by the British Pain Society. Br J 64 National Committee for Quality Assurance. NCQA offers RNs new practice-and reimbursement-oppor-
Anaesth 2014; 112: 16–24. Patient Centered Medical Home. Washington, DC: tunities. Am J Nurs 2012; 112: 54–9.
49 Lyrica (pregabalin) capsules, CV; Lyrica (prega- National Committee for Quality Assurance, 2015. 79 Berenson RA, Devers KJ, Burton RA. Will the Patient-
balin) oral solution, CV, [package insert]. New 65 Bojadzievski T, Gabbay RA. Patient-centered medi- Centered Medical Home Transform the Delivery of
York, NY: Pfizer Pharmaceuticals, 2013. cal home and diabetes. Diabetes Care 2011; 34: Health Care? Washington, DC: Urban Institute, 2011.
50 Cymbalta (duloxetine delayed-release capsules) for 1047–53. 80 Schram AP. The patient-centered medical home: trans-
oral use [package insert]. Indianapolis, IN: Lilly 66 Wang QC, Chawla R, Colombo CM, Snyder RL, forming primary care. Nurse Pract 2012; 37: 33–9.
USA, LLC, 2012. Nigam S. Patient-centered medical home impact 81 Willard R, Bodenheimer T. The Building Blocks of
51 Savella (milnacipran HCl) tablets [package insert]. on health plan members with diabetes. J Public High-Performing Primary Care. Oakland, CA: Cali-
St. Louis, MO: Forest Laboratories, Inc., 2013. Health Manag Pract 2014; 20: E12–20. fornia Healthcare Foundation, 2012.
52 Traynor LM, Thiessen CN, Traynor AP. Pharma- 67 Ackroyd SA, Wexler DJ. Effectiveness of diabetes 82 Cronholm PF, Shea JA, Werner RM et al. The
cotherapy of fibromyalgia. Am J Health Syst Pharm interventions in the patient-centered medical home. patient centered medical home: mental models and
2011; 68: 1307–19. Curr Diabetes Rep 2014; 14: 471. practice culture driving the transformation process.
53 Smith HS, Bracken D, Smith JM. Pharmacotherapy 68 Taliani CA, Bricker PL, Adelman AM, Cronholm J Gen Intern Med 2013; 28: 1195–201.
for fibromyalgia. Frontiers Pharmacol 2011; 2: 17. PF, Gabbay RA. Implementing effective care man- 83 Scholle SH, Asche SE, Morton S et al. Support and
54 Arnold LM. Biology and therapy of fibromyalgia. agement in the patient-centered medical home. Am strategies for change among small patient-centered
New therapies in fibromyalgia. Arthritis Res Ther J Manag Care 2013; 19: 957–64. medical home practices. Ann Family Med 2013; 11
2006; 8: 212. 69 Randall I, Mohr DC, Maynard C. VHA patient- (Suppl. 1): S6–13.
55 Martin SA, Coon CD, McLeod LD, Chandran A, centered medical home associated with lower rate 84 Arnold LM, Stanford SB, Welge JA, Crofford LJ.
Arnold LM. Evaluation of the fibromyalgia diag- of hospitalizations and specialty care among veter- Development and testing of the fibromyalgia diag-
nostic screen in clinical practice. J Eval Clin Pract ans with posttraumatic stress disorder. J Healthc nostic screen for primary care. J Womens Health
2014; 20: 158–65. Qual 2014. doi:10.1111/jhq.12092. [Epub ahead of (Larchmt) 2012; 21: 231–9.
56 Masters ET, Mardekian J, Emir B et al. Electronic print] 85 Baron R, Perrot S, Guillemin I et al. Improving the pri-
medical record data to identify variables associ- 70 Amiel JM, Pincus HA. The medical home model: mary care physicians’ decision making for fibromyalgia
ated with a fibromyalgia diagnosis: importance of new opportunities for psychiatric services in the in clinical practice: development and validation of the
health care resource utilization. J Pain Res 2015; United States. Curr Opin Psychiatry 2011; 24: 562–8. Fibromyalgia Detection (FibroDetect) screening tool.
8: 131–8. 71 Evans L, Whitham JA, Trotter DR, Filtz KR. An Health Qual Life Outcomes 2014; 12: 128.
57 California Heathcare Foundation. Chronic Disease evaluation of family medicine residents’ attitudes 86 Fox BP. A PCMH model that works. Reflections
Registries: A Product Review. Oakland, CA, Sacra- before and after a PCMH innovation for patients on the PBS Special. http://www.medscape.com/
mento, CA: California Healthcare Foundation, 2015. with chronic pain. Fam Med 2011; 43: 702–11. viewarticle/841916 (accessed June 4, 2015).
58 American College of Physicians. Joint Principles of 72 Porter ME, Pabo EA, Lee TH. Redesigning primary 87 Serio CD, Hessing J, Reed B, Hess C, Reis J. The
the Patient Centered Medical Home. Philadelphia, care: a strategic vision to improve value by organiz- effect of online chronic disease personas on activa-
PA: American College of Physicians, 2007. ing around patients’ needs. Health Aff (Millwood) tion: within-subjects and between-groups analyses.
59 National Committee for Quality Assurance website. 2013; 32: 516–25. JMIR Res Protoc 2015; 4: e20.
The future of patient-centered medical homes: foun- 73 Peikes DN, Reid RJ, Day TJ et al. Staffing patterns
dation for a better health care system. www.ncqa.org/ of primary care practices in the comprehensive
Portals/0/Public Policy/2014 Comment Letters/The_- primary care initiative. Ann Fam Med 2014; 12: Paper received July 2015, accepted October 2015
Future_of_PCMH.pdf (accessed September 22, 2015). 142–9.
ª 2016 The Authors International Journal of Clinical Practice Published by John Wiley & Sons Ltd
Int J Clin Pract, February 2016, 70, 2, 99–111
112 Fibromyalgia management for primary care providers
Behavioural health worker Support staff worker who provides psychological therapeutic support to patients with behavioural
health issues and psychological disorders; generally requires a qualification in psychology, social work,
counselling or nursing
Care coordinator Liaises between patients and other healthcare professionals; ensures patients understand their medical
condition and treatment, locates community resources and coordinates patient care services and
referrals
Dietician An expert in human nutrition and the regulation of diet; advises people on what to eat to achieve
health-related goals
Health coach An individual trained to assist patients by promoting coping behaviours, goal setting and overcoming
negativity; generally requires a qualification in exercise science, nutrition, health care or wellness.
Similar processes may also be performed by a psychotherapist
Healthcare professional (HCP) Any individual trained to provide healthcare services; may include physicians, nurses, therapists and
support workers
Medical assistant A healthcare professional supporting physicians and other healthcare providers; they perform routine
tasks and procedures such as measuring vital signs, collecting biological specimens, completing
electronic medical records and scheduling appointments. Qualifications and requirements for
certification vary between jurisdictions
Nurse practitioner An advanced practice registered nurse who has been trained to diagnose and manage acute illness and
chronic conditions. A nurse practitioner may serve as a primary care provider; in the USA, depending
upon which state they work in, nurse practitioners may or may not be required to practice under the
supervision of a physician
Pharmacist Healthcare professional who understands the mechanisms and actions of drugs, side effects, drug
interactions and monitoring requirements; they provide pharmaceutical information and oversee the
dispensation of prescription medication as well as non-prescription or over-the-counter drugs.
A further education qualification is required
Physical therapist Rehabilitation professional who manages patients with health conditions that limit their ability to move
and perform functional activities
Physician assistant A healthcare professional who is licenced to practice medicine as part of a team with physicians and
other providers; may be known as a physician associate in the UK. A physician assistant may conduct
physical exams, order tests, diagnose and treat illnesses and perform medical procedures under the
supervision of another physician
Primary care physician A physician who provides the first point of contact for a patient and continuing care of medical
conditions; may be known as a general practitioner in English-speaking countries outside of the USA
Primary care provider A healthcare professional providing day-to-day health care in a primary care setting; may be a primary
care physician, nurse practitioner or physician assistant
Psychiatrist A physician specialising in the diagnosis and treatment of mental disorders
Registered nurse A nurse who has undergone training and met the requirements to obtain a nursing licence
Specialist A physician or surgeon who has completed further medical education and training in a specific branch
of medical practice
ª 2016 The Authors International Journal of Clinical Practice Published by John Wiley & Sons Ltd
Int J Clin Pract, February 2016, 70, 2, 99–112